Recruiting NA Type 2 Diabetes

New treatment option for Type 2 Diabetes

Official title Glycemic Excursion Minimization (GEM) to Outshine Health Disparities

ClinicalTrials.gov ID: NCT06236581

What this study is testing

What it's testing
The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, reduce diabetes distress, and increase empowerment and confidence in managing diabetes.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • type 2 diabetes
  • capable of making dietary and physical activity changes

You likely can't join if

  • on insulin or secretagogue
  • on medications that impede weight loss (e.g., prednisone)
  • pregnant or planning pregnancy in the next 2 months
  • no history of moderate to severe hypoglycemia

The study team makes the final eligibility decision.

Where it's taking place

  • Augusta, Georgia, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Augusta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.